Endarterectomy or Carotid Artery Stenting? A Question That Still Generates Studies

Endarterectomy or Carotid Artery Stenting? A Question That Still Generates Studies

There have been several studies offering contradictory data on the relative effectiveness of carotid artery stenting and carotid artery endarterectomy for the prevention of stroke due to carotid artery stenosis.

 

The authors of this study performed a meta-analysis assessing the efficacy of these techniques, given recently published clinical trial data.

 

They selected randomized trials with at least 50 patients published as of April 30th, 2016, in order to compare both alternatives. Stenting had to include the use of distal-protection devices.

 

The study analyzed 6526 patients from 5 randomized trials with a mean follow-up of 5.3 years. The composite endpoint of peri-procedural death, infarction or stroke, plus non-peri-procedural ipsilateral stroke was similar between techniques (odds ratio [OR]: 1.22; 95% confidence interval [CI]: 0.94 to 1.59).

 

The risk of any peri-procedural stroke plus non-peri-procedural ipsilateral stroke was higher for patients who underwent stenting (OR: 1.50; 95% CI: 1.22 to 1.84). This higher risk of stroke was mostly attributed to peri-procedural minor stroke (OR: 2.43; 95% CI: 1.71 to 3.46).

 

Stenting was also associated with significantly lower risk of peri-procedural infarction (OR: 0.45; 95% CI: 0.27 to 0.75) and cranial nerve palsy.

 

Conclusion

Both carotid artery stenting and endarterectomy were associated with similar rates of a composite endpoint of peri-procedural death, infarction or stroke, plus non-peri-procedural ipsilateral stroke. The risk of long-term overall stroke was higher with stenting, mostly due to peri-procedural minor stroke, and lower rates of infarction and cranial nerve palsy than surgery.

 

Original title: Carotid Artery Stenting Versus Endarterectomy for Stroke Prevention. A Meta-Analysis of Clinical Trials.

Reference: Partha Sardar et al. J Am Coll Cardiol 2017;69:2266-75.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...